Affiliation:
1. Fujian Cancer Hospital
2. Fujian Provincial Hospital
3. Fujian Medical University
Abstract
Abstract
Background: Due to the heterogeneity of MCI, the key points of non-drug therapies cannot be determined. Exploring the characteristics among different MCI subgroups would therefore be beneficial in guiding the development of non-drug therapies. In the present study, weexplored subgrouping of older Chinese adults with MCI based on cognitive function and analyzed the characteristics of the resulting subgroups.
Methods: A cross-sectional study was conducted between October 2018 and January 2022. The study enrolled a total of 1017 participants with MCI in Fujian, East China. Participants underwent a comprehensive neuropsychological test assessing memory, language, attention, and executive function and completed a questionnaire examining socioeconomic and clinical variables.Neuropsychological test scores were transformed to z-scores, which were then examined using latent class analysis. Correlations of socioeconomic and clinical variables with MCI subgroups were assessed using multinomial logistic regression analysis.
Results: Three MCI subgroups were identified: (1) false-positive MCI (56.64%); (2) early MCI (36.28%); and (3) late MCI (7.08%). Age, data sources, marriage status, living status, and participation in intellectual activities differed significantly across the three MCI subgroups (P<0.05). Compared with the false-positive MCI group, participants with late MCI were less likely to participate in intellectual activity and more likely to live in a nursing home.
Conclusions: Older Chinese adults with MCI can be classified into subgroups based on cognitive function. A large proportion of participants were classified in the false-positive MCI group, suggesting that conventional diagnostic criteria are susceptible to false-positive errors, resulting in patients being misdiagnosed as MCI in China. And further research to define the characteristics of different MCI subgroups could facilitate the development of non-drug therapies for MCI.
Publisher
Research Square Platform LLC
Reference57 articles.
1. Causes and patterns of dementia: an update in the era of redefining Alzheimer's disease;James BD;Annu Rev Public Health,2019
2. Clinical practice. Mild cognitive impairment;Petersen RC;N Engl J Med,2011
3. State Statistical Bureau, Council Office of the Leading Group for the Seventh National Census of the State. Bulletin of the Seventh National Census (No. 7) - Urban and Rural Population and Floating Population. Accessed 11 May 2021.
4. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study;Jia L;Lancet Public Health,2020
5. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease;Jack CRJ;Alzheimers Dement,2018